CA3122767C - Stereoselective total synthesis of noribogaine - Google Patents
Stereoselective total synthesis of noribogaine Download PDFInfo
- Publication number
- CA3122767C CA3122767C CA3122767A CA3122767A CA3122767C CA 3122767 C CA3122767 C CA 3122767C CA 3122767 A CA3122767 A CA 3122767A CA 3122767 A CA3122767 A CA 3122767A CA 3122767 C CA3122767 C CA 3122767C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- noribogaine
- group
- conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568568P | 2011-12-08 | 2011-12-08 | |
| US61/568,568 | 2011-12-08 | ||
| CA2856551A CA2856551C (en) | 2011-12-08 | 2012-12-03 | Stereoselective total synthesis of noribogaine |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2856551A Division CA2856551C (en) | 2011-12-08 | 2012-12-03 | Stereoselective total synthesis of noribogaine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3122767A1 CA3122767A1 (en) | 2013-06-13 |
| CA3122767C true CA3122767C (en) | 2023-03-28 |
Family
ID=48575047
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3122767A Active CA3122767C (en) | 2011-12-08 | 2012-12-03 | Stereoselective total synthesis of noribogaine |
| CA2856551A Active CA2856551C (en) | 2011-12-08 | 2012-12-03 | Stereoselective total synthesis of noribogaine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2856551A Active CA2856551C (en) | 2011-12-08 | 2012-12-03 | Stereoselective total synthesis of noribogaine |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8937061B2 (enExample) |
| EP (1) | EP2788355A4 (enExample) |
| JP (1) | JP2015509076A (enExample) |
| CN (1) | CN104364256A (enExample) |
| CA (2) | CA3122767C (enExample) |
| HK (1) | HK1204604A1 (enExample) |
| IL (1) | IL232724A (enExample) |
| IN (1) | IN2014CN04160A (enExample) |
| WO (1) | WO2013085850A2 (enExample) |
| ZA (1) | ZA201403995B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| MX2013000733A (es) | 2010-07-23 | 2013-05-30 | Demerx Inc | Composiciones de noribogaina. |
| EP2481740B1 (en) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
| US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
| CA3122767C (en) | 2011-12-08 | 2023-03-28 | Demerx, Inc. | Stereoselective total synthesis of noribogaine |
| WO2013112757A1 (en) * | 2012-01-25 | 2013-08-01 | Demerx, Inc. | Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| AU2013212139A1 (en) * | 2012-01-25 | 2014-06-26 | Demerx, Inc. | Synthetic voacangine |
| WO2014098877A1 (en) | 2012-12-20 | 2014-06-26 | Demerx, Inc. | Substituted noribogaine |
| CA3256416A1 (en) | 2013-03-15 | 2025-06-21 | Demerx, Inc. | METHOD FOR THE TREATMENT OF ADDICTION IN PATIENTS UNDER METHADONE WITH NORIBOGAINE |
| KR20160120781A (ko) | 2014-02-18 | 2016-10-18 | 데메알엑스, 인크. | 약물 중독의 급성 및 장기간 치료 방법 |
| US9561232B2 (en) | 2014-02-18 | 2017-02-07 | Demerx, Inc. | Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use |
| US9345711B2 (en) | 2014-02-18 | 2016-05-24 | Demerx, Inc. | Methods for acute and long-term treatment of drug addiction |
| US9591978B2 (en) | 2014-03-13 | 2017-03-14 | Demerx, Inc. | Methods and compositions for pre-screening patients for treatment with noribogaine |
| US9550789B2 (en) | 2014-06-18 | 2017-01-24 | Demerx, Inc. | Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them |
| US9549935B2 (en) | 2014-07-14 | 2017-01-24 | Demerx, Inc. | Methods and compositions for treating migraines using noribogaine |
| PT3223906T (pt) | 2014-11-26 | 2021-05-05 | Demerx Inc | Métodos e composições para potencializar a ação de analgésicos de opioides usando alcaloides de iboga |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| US12377112B2 (en) | 2019-04-17 | 2025-08-05 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| US20240100061A1 (en) | 2022-09-14 | 2024-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions of Iboga Alkaloids and Methods of Treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2813873A (en) * | 1957-11-19 | Derivatives of the ibogaine alkaloids | ||
| US3639408A (en) * | 1967-06-03 | 1972-02-01 | Shionogi & Co | Process for the preparation of isoquinuclidine derivatives |
| AU4613296A (en) | 1994-07-25 | 1996-04-19 | Nda International, Inc. | A method of treating chemical dependency in mammals and a composition therefor |
| US5616575A (en) * | 1995-12-04 | 1997-04-01 | Regents Of The University Of Minnesota | Bioactive tricyclic ibogaine analogs |
| EP2246058A1 (en) * | 1997-09-04 | 2010-11-03 | Novoneuron, Inc. | Noribogaine in the treatment of pain and drug addiction |
| US7220737B1 (en) * | 1997-09-04 | 2007-05-22 | Novoneuron, Inc | Noribogaine in the treatment of pain and drug addiction |
| CN102225937B (zh) * | 2011-05-04 | 2012-07-25 | 中国科学院昆明植物研究所 | 抗肿瘤生物碱类化合物，其药物组合物及其制备方法和应用 |
| CA3122767C (en) | 2011-12-08 | 2023-03-28 | Demerx, Inc. | Stereoselective total synthesis of noribogaine |
-
2012
- 2012-12-03 CA CA3122767A patent/CA3122767C/en active Active
- 2012-12-03 IN IN4160CHN2014 patent/IN2014CN04160A/en unknown
- 2012-12-03 HK HK15103583.0A patent/HK1204604A1/xx unknown
- 2012-12-03 CN CN201280058362.5A patent/CN104364256A/zh active Pending
- 2012-12-03 CA CA2856551A patent/CA2856551C/en active Active
- 2012-12-03 WO PCT/US2012/067629 patent/WO2013085850A2/en not_active Ceased
- 2012-12-03 JP JP2014545969A patent/JP2015509076A/ja active Pending
- 2012-12-03 EP EP12855135.5A patent/EP2788355A4/en not_active Withdrawn
- 2012-12-07 US US13/708,834 patent/US8937061B2/en active Active
-
2014
- 2014-05-20 IL IL232724A patent/IL232724A/en not_active IP Right Cessation
- 2014-05-30 ZA ZA2014/03995A patent/ZA201403995B/en unknown
- 2014-09-15 US US14/486,804 patent/US9403837B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013085850A3 (en) | 2014-12-18 |
| US8937061B2 (en) | 2015-01-20 |
| HK1204604A1 (en) | 2015-11-27 |
| EP2788355A2 (en) | 2014-10-15 |
| US20130165647A1 (en) | 2013-06-27 |
| WO2013085850A2 (en) | 2013-06-13 |
| US9403837B2 (en) | 2016-08-02 |
| CN104364256A (zh) | 2015-02-18 |
| CA2856551C (en) | 2021-06-22 |
| IL232724A (en) | 2017-07-31 |
| CA2856551A1 (en) | 2013-06-13 |
| JP2015509076A (ja) | 2015-03-26 |
| CA3122767A1 (en) | 2013-06-13 |
| EP2788355A4 (en) | 2015-10-21 |
| IL232724A0 (en) | 2014-08-03 |
| IN2014CN04160A (enExample) | 2015-07-17 |
| ZA201403995B (en) | 2016-09-28 |
| US20150005492A1 (en) | 2015-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3122767C (en) | Stereoselective total synthesis of noribogaine | |
| EP1539764B1 (en) | Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. | |
| EP1233964B1 (en) | New use and novel n-azabicyclo-amide derivatives | |
| KR970007917B1 (ko) | 신규 삼환식 화합물 | |
| JP5465241B2 (ja) | ５−ｈｔ３受容体調節物質ならびにその作製方法および使用 | |
| AU2009342654B2 (en) | Morphinan derivatives with high oral bioavailability | |
| EP1414819A1 (en) | THERAPEUTIC 1H-PYRIDO 4,3-b]INDOLES | |
| EP2788003A1 (en) | Phosphate esters of noribogaine | |
| HUT60270A (en) | Process for producing alpha-oxoacetamide derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
| BRPI0619705A2 (pt) | composto, composição farmacêutica, método para ligar receptores a opióide num paciente, método para tratar disfunção gastrointestinal, método para tratar ìleo, método para tratar obesidade, método para tratar um efeito colateral associado com um opióide composto e método para tratar dor | |
| JP5123429B2 (ja) | インドリン抗癌剤 | |
| MXPA00012248A (es) | Incrementadores de acetilcolina. | |
| AU2010214685C1 (en) | Noribogaine compositions | |
| AU2012202509B2 (en) | Noribogaine compositions | |
| Ramakrishnan et al. | Synthesis and biological evaluation of a metazocine-containing enkephalinamide. Evidence for nonidentical roles of the tyramine moiety in opiates and opioid peptides | |
| WO1993007871A1 (en) | Methods for the treatment of hyperlipidemia using azaspiranes | |
| US5455247A (en) | Methods for the treatment of hyperlipidemia using azaspiranes | |
| WO1994009007A1 (en) | 3a,6-bridged octahydroisoindoles and related hydroisoquinolines and hydrobenzazepines and their use as pharmaceutical and radioimaging agents | |
| HK40025994B (en) | Salt of phenylpropionamide derivative and preparation method therefor | |
| HK40025994A (en) | Salt of phenylpropionamide derivative and preparation method therefor | |
| HK1147035B (en) | Indoline anti-cancer agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| EEER | Examination request |
Effective date: 20210617 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241125 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241125 |